RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Elevating compliance to achieve a strategic advantage – going beyond just meeting regulatory requirements for an innovative drug, biologic or medical device – allows biopharmaceutical companies to respond more rapidly to ever-changing conditions in the New Health, according to a new report from Consulting at Quintiles.
